5883 DAN 10
Pill imprint 5883 DAN 10 has been identified as Methylphenidate hydrochloride 10 mg.
Methylphenidate is used in the treatment of adhd; narcolepsy; depression; fatigue; severe mood dysregulation and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy.
Methylphenidate 10 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.
Methylphenidate hydrochloride Images
- Imprint:
-
5883
DAN 10 - Strength:
- 10 mg
- Color:
- Green
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Watson Pharmaceuticals
More Methylphenidate Hydrochloride resources
- Methylphenidate
- Methylphenidate (Wolters Kluwer)
- Methylphenidate Chewable Tablets (Wolters Kluwer)
- Methylphenidate Controlled-Release Capsules (Wolters Kluwer)
- Methylphenidate Controlled-Release Tablets (Wolters Kluwer)
- Methylphenidate Extended-Release Capsules (Wolters Kluwer)
- Methylphenidate Extended-Release Tablets (Wolters Kluwer)
- Methylphenidate Solution (Wolters Kluwer)
- Methylphenidate System (Wolters Kluwer)
- methylphenidate (Cerner Multum)
- methylphenidate transdermal (Cerner Multum)
- methylphenidate Oral, Transdermal (Micromedex) - Includes Dosage Information
- methylphenidate Transdermal (Micromedex) - Includes Dosage Information
- Methylphenidate Hydrochloride (AHFS DI)
- Methylin Chewable Tablets (FDA)
- Methylin Oral Solution (FDA)
- Methylphenidate Hydrochloride (FDA)
- Methylphenidate Oral Solution (FDA)
- Methylphenidate Tablets (FDA)
- Methylphenidate Hydrochloride (Wolters Kluwer)


